Rhino-Orbital-Cerebral Mucormycosis (ROCM)

Rhino-orbital-cerebral mucormycosis, often shortened to ROCM, is a very serious fungal infection that usually starts in the nose and the sinuses, then can spread to the eye socket (the orbit) and sometimes to the brain. The fungi belong to a group called Mucorales (commonly Rhizopus, Mucor, Lichtheimia, and related molds). These molds live in soil and decaying plants, and most people breathe in their spores every day without any problem. People get sick mainly when their immune system is weak or their blood sugar is very high, because the body’s first-line defenses cannot kill the spores. The fungus grows as wide ribbon-like filaments that invade blood vessels, block blood flow, and cause tissue death (necrosis), which is why doctors look for dark, dead tissue in the nose or palate. Early recognition and urgent diagnosis are critical because the disease can spread quickly. CDC

Rhino-orbital-cerebral mucormycosis is a fast-spreading fungal infection that begins in the nose and sinuses, can move into the eye socket, and may reach the brain. The fungus lives widely in soil and decaying organic matter and usually does not hurt healthy people. It becomes dangerous when body defenses are weakened, such as with poorly controlled diabetes (especially diabetic ketoacidosis), severe COVID-19 illness, major steroid use, organ or stem-cell transplantation, cancer, or very low white blood cells. When the fungus enters the nose, it can invade blood vessels, cut off blood supply, and cause tissue death. Because blood flow is blocked, the infection can gallop ahead and needs urgent, aggressive treatment. The backbone of care is early antifungal medicine plus rapid removal of dead and infected tissue, while also fixing the medical problems that allowed the infection to take hold. CDC+1PMC

ROCM is most often seen in people with poorly controlled diabetes (especially when diabetic ketoacidosis is present) and in people who are immunocompromised for other reasons, such as cancer chemotherapy, organ or stem-cell transplants, long courses of corticosteroids, prolonged neutropenia, iron overload (including deferoxamine therapy), malnutrition, severe trauma or burns, and sometimes in the setting of severe COVID-19. These risks increase because high sugar, acid-base disturbances, and certain drugs reduce the ability of immune cells to kill the spores and can increase available iron that the fungus uses to grow. CDCNCBI

---

Types

Doctors describe types of mucormycosis by where it starts and how far it has spread. For this topic we focus on the head and face, but knowing the broader picture helps.

By body site

• Rhinocerebral / rhino-orbital-cerebral: starts in the nasal cavity and sinuses; may spread to the orbit and brain. This is common in people with diabetes. CDC

• Other forms exist (pulmonary, cutaneous, gastrointestinal, disseminated), but those are beyond our scope here. CDC

By extent in the head and face

• Rhino-sinus mucormycosis: disease is limited to the nose and paranasal sinuses.

• Rhino-orbital mucormycosis: disease has spread into the orbit, causing eye pain, swelling, double vision, or vision loss.

• Rhino-orbito-cerebral mucormycosis: disease has moved further toward the cavernous sinus or brain, causing cranial nerve problems, stroke-like symptoms, or seizures.

By speed

• Acute fulminant: very rapid onset over days and rapid tissue death because the fungus invades arteries and veins.

• Chronic or indolent: slower course over weeks in a minority of cases.

By clinical certainty (useful at the bedside)

• Possible ROCM: typical symptoms in a high-risk person.

• Probable ROCM: symptoms plus suggestive endoscopy or imaging.

• Proven ROCM: symptoms plus microbiology or histopathology showing Mucorales in tissue. This “possible/probable/proven” framework is widely used in practice to guide speed of action. Lippincott Journals

---

Causes

1. Uncontrolled diabetes mellitus: high blood sugar weakens the white blood cells that normally kill fungal spores, and ketoacidosis changes body chemistry in ways that help the fungus grow. NCBI

2. Diabetic ketoacidosis (DKA): acid in the blood and shifts in iron availability allow the fungus to thrive and invade blood vessels rapidly. NCBI

3. Prolonged or high-dose corticosteroids: steroids suppress immunity and raise blood sugar, which together lower resistance to Mucorales. CDC

4. Hematologic cancers (like leukemia) and their treatments: these reduce neutrophils and other defenses that normally stop fungi at the sinus lining. NCBI

5. Stem-cell or solid-organ transplantation: anti-rejection drugs and profound immunosuppression increase risk. CDC

6. Persistent neutropenia: very low neutrophil counts remove a key defense against hyphal invasion. CDC

7. Iron overload: excess available iron fuels fungal growth; deferoxamine can act like a siderophore for the fungus and worsen risk. NCBI

8. Severe COVID-19 illness: inflammation, high ferritin, oxygen therapy, and steroid use during treatment can combine to create vulnerability. SpringerOpen

9. Chronic kidney disease: metabolic changes and frequent steroid or immunosuppressive use can lower defenses.

10. Uncontrolled HIV infection or other immunodeficiencies: reduced cell-mediated immunity weakens mucosal defenses.

11. Malnutrition: poor nutrition weakens barriers and immune responses, making fungal spread more likely. CDC

12. Intravenous drug use: injection-related contamination and immune effects are recognized contributors. CDC

13. Major trauma or burns: damaged tissue and dressings provide entry points for spores and reduce local blood supply. CDC

14. Contaminated medical supplies or environments (rare outbreaks): contaminated linens, bandages, or dust in hospitals have been linked to clusters. CDC

15. Recent maxillofacial or dental procedures in high-risk people: instrumented tissues with poor blood supply can be vulnerable if immunity is low.

16. Prolonged ICU care with broad-spectrum antibiotics: these situations select for unusual infections and often require steroids or devices.

17. Use of certain antifungals that do not cover Mucorales (e.g., voriconazole): suppresses other molds while Mucorales remain unchecked, allowing breakthrough infection in high-risk hosts. SpringerOpen

18. Prematurity in newborns (for GI forms): immature immunity creates vulnerability; included here for completeness across the spectrum. CDC

19. Poor glycemic control after COVID-19: stress hyperglycemia and steroid therapy together can tip a person into very high sugars, seeding sinuses with spores that then invade. SpringerOpen

20. Any combination of the above: risks add up; diabetes plus steroids plus recent hospitalization creates a much higher danger than any single factor alone.

---

Symptoms

1. One-sided facial pain or swelling: early infection in a sinus often causes deep ache and swelling on that side of the face.

2. Nasal stuffiness or bloody discharge: the nose may feel blocked, with blood-tinged or blackish discharge as tissues die.

3. Fever and general unwell feeling: fever may be present but is not always, so lack of fever does not rule it out. CDC

4. Headache centered around the eye or forehead: inflammation of ethmoid, maxillary, or sphenoid sinuses can cause this pattern.

5. Loss of smell or taste: damaged nasal mucosa can reduce smell, and taste can seem dull because smell is impaired.

6. Numbness or tingling of cheek or upper teeth: involvement of nerves around the maxillary sinus can cause sensory changes.

7. Toothache or loosening of teeth on one side: the fungus invading the palate or upper jaw can cause tooth pain or mobility.

8. Blackish scab in the nose or on the roof of the mouth: this “eschar” is a key warning sign because it reflects tissue death from blocked blood vessels. CDC

9. Eye pain or swelling of the eyelids: spread into the orbit causes sharp pain and swelling around the eye.

10. Double vision or drooping eyelid: the muscles and nerves that move the eye can be damaged, so the eye does not track normally.

11. Protruding eye (proptosis): pressure from inflamed tissues in the orbit can push the eye forward.

12. Sudden decrease in vision or vision loss: the optic nerve or retinal blood supply may be compromised.

13. Difficulty moving one side of the face or problems with facial sensation: cranial nerves can be affected as the infection approaches the cavernous sinus.

14. Confusion, weakness, or stroke-like symptoms: if the infection reaches the brain or large blood vessels, neurological signs can appear.

15. Seizures: brain involvement can provoke seizures and signals the need for urgent imaging and ICU-level care.

(Doctors emphasize that ROCM can progress fast, so these symptoms, especially in a high-risk person, should trigger urgent evaluation.) Lippincott Journals

---

Diagnostic tests

A) Physical examination

1. Focused head-and-neck exam
   A clinician looks carefully for one-sided swelling, redness, tenderness over the sinuses, and numb spots on the face. These clues show where the infection may have started and how far it has traveled.

2. Nasal and oral cavity inspection with a light
   Doctors look for black or gray dead tissue (eschar) on the nasal septum, turbinates, or the hard palate. The presence of dark dead tissue is a red flag because it reflects blood vessel invasion and tissue death. CDC

3. Cranial nerve examination
   Simple bedside checks of eye movements, facial sensation, facial muscle strength, and jaw function help detect spread toward the cavernous sinus and skull base.

4. Bedside eye examination
   Visual acuity, color vision, pupil reactions, and quick checks of eye position and movement reveal orbital involvement and optic nerve compromise.

B) Manual/bedside tests

5. Anterior rhinoscopy or office nasal endoscopy
   With a speculum or a thin flexible scope, the doctor looks inside the nose for swollen pale mucosa, black crusts, pus, and areas that do not bleed when touched, which suggests dead tissue. This helps choose the best spot for a diagnostic swab or biopsy the same day. Lippincott Journals

6. Palpation and percussion of the sinuses and teeth
   Gentle tapping over the sinuses and upper teeth can localize pain and identify dental involvement when the maxilla or palate is affected.

7. Bedside vision checks and ocular motility testing
   Reading charts, finger counting, and following a moving target quickly show whether vision or eye movements are deteriorating, which signals urgent orbital imaging.

8. Bedside neurological screening
   Checking orientation, limb strength, coordination, and signs of meningeal irritation can reveal early brain involvement and helps triage to emergency imaging.

C) Laboratory and pathological tests

9. Direct microscopy of a nasal/sinus specimen (KOH, calcofluor white)
   A swab or tissue sample from the involved area is examined under the microscope. Broad pauciseptate hyphae branching at irregular angles suggest Mucorales. A positive microscopy result fast-tracks treatment while waiting for culture. ECMM

10. Histopathology of tissue (H&E, PAS, GMS stains)
    A small biopsy shows hyphae invading tissue and blood vessels, which confirms invasive disease. Characteristic broad, ribbon-like, sparsely septate hyphae are seen with special stains and are highly suggestive of mucormycosis. ECMM

11. Fungal culture from tissue
    Culture helps identify the fungus to genus or species (e.g., Rhizopus arrhizus) and may allow antifungal susceptibility testing. Culturing tissue (not just surface swabs) is recommended; laboratories may incubate at different temperatures to improve yield. ECMM

12. Molecular assays (PCR or sequencing on tissue)
    When available, molecular tests increase specificity and can identify the organism even if culture is negative. These methods are useful at centers with mycology expertise. ECMM

13. Serum tests to rule in other molds (with an important caveat)
    Common blood biomarkers like (1→3)-β-D-glucan and galactomannan do not detect Mucorales reliably, so a negative result does not exclude ROCM; this helps prevent false reassurance and keeps the focus on tissue diagnosis. CDC

14. Baseline medical labs to assess risk and readiness for treatment
    Glucose, ketones, complete blood count, kidney and liver function, ferritin, and iron studies help correct risk factors and prepare for imaging with contrast or other therapies; while not diagnostic on their own, they are essential in the ROCM workup. CDC

D) Electrodiagnostic tests

15. Electroencephalography (EEG)
    If seizures or altered mental status occur, EEG looks for abnormal brain electrical activity related to cerebral involvement. This does not diagnose the fungus but documents complications that guide ICU care.

16. Visual evoked potentials (VEP)
    When vision is dropping and the optic nerve is threatened, VEP assesses the functional integrity of the visual pathway; this complements imaging and eye exam by showing the physiologic impact of orbital or intracranial spread.

E) Imaging tests

17. Contrast-enhanced MRI of the paranasal sinuses, orbits, and brain
    MRI is usually preferred for the orbit and brain because it shows soft tissues, optic nerve, cavernous sinus, and early ischemia. An early clue is the “black turbinate sign” (non-enhancing turbinates due to tissue necrosis); however, this sign is not specific, so radiologists interpret it with all other findings. MRI also shows spread without obvious bone destruction because the fungus can travel along blood vessels and nerves. SpringerOpen

18. CT scan of paranasal sinuses and orbit
    CT is fast and excellent for mapping sinus involvement, subtle bone changes, and air-fluid levels. It helps surgeons plan debridement and can be done immediately in unstable patients when MRI is not feasible. ECMM

19. MR angiography/venography or CT angiography
    These studies evaluate cavernous sinus thrombosis, internal carotid artery narrowing or occlusion, and other vessel problems caused by angioinvasion, which is a hallmark of mucormycosis. Detecting these complications early is vital for prognosis and surgical planning. SpringerOpen

20. Targeted imaging follow-up
    Because the disease can evolve quickly, experienced teams repeat imaging to reassess the extent and to guide further surgery or interventions, especially when the patient is unstable. Best-practice guidelines support early imaging at suspicion and structured reassessment thereafter. ECMM

Non-pharmacological treatments (therapies and “other” actions)

Below are supportive measures in addition to antifungal drugs and surgeries. Each has a short description, purpose, and “how it helps.”

1. Immediate hospital admission and triage
   Purpose: start life-saving care without delay.
   How it helps: rapid imaging, urgent ENT/eye evaluation, labs, and early antifungal therapy lower the risk of spread and death. CDC

2. Multidisciplinary team management
   Purpose: coordinate ENT, ophthalmology, infectious disease, neurology/neurosurgery, dentistry, ICU, and rehabilitation.
   How it helps: faster decisions on debridement, eye-saving steps, and brain protection improve outcomes. Lippincott Journals

3. Tight glucose monitoring and ketoacidosis correction protocols
   Purpose: remove the fuel that helps mucor grow.
   How it helps: normalizing blood sugar and correcting acid levels reduce fungal advantage and vessel damage. (Medication is used, but the protocol and monitoring are non-drug steps.) CDC

4. Stop or taper unnecessary steroids and immunosuppression (when clinically safe)
   Purpose: allow immune recovery.
   How it helps: fewer steroids means better neutrophil function and less sugar elevation. Coordination with the treating team is essential. CDC

5. Head elevation and sinus drainage positioning
   Purpose: improve sinus ventilation and reduce pressure.
   How it helps: better drainage can lower crusting and discomfort, helping debridement and topical care.

6. Endoscopic bedside debridement of crusts and eschar (minor, non-OR)
   Purpose: remove dead debris early and often.
   How it helps: decreases fungal load and improves penetration of topical care between operations.

7. Sterile saline nasal irrigations
   Purpose: soften crusts and improve hygiene.
   How it helps: gentle irrigation with sterile saline keeps passages clear; never use non-sterile water because of infection risk. PMC

8. Strict oxygen-equipment and humidifier hygiene
   Purpose: avoid secondary contamination.
   How it helps: using sterile water and cleaning circuits lowers risk for vulnerable patients during oxygen therapy. World Health Organization

9. Protect the eye surface (shielding and eyelid taping as needed)
   Purpose: prevent exposure keratopathy when eyelids don’t close or sensation is reduced.
   How it helps: preserves corneal health during swelling and after surgery.

10. Comprehensive oral and dental care
    Purpose: remove dental sources of infection and protect the palate and maxilla.
    How it helps: lowers bacterial load, protects surgical sites, and supports feeding plans.

11. Nutrition therapy with a high-protein, calorie-adequate plan
    Purpose: support healing and immune work.
    How it helps: protein and energy needs rise with infection and surgery; dietitians help prevent malnutrition.

12. Early, repeated imaging (contrast MRI/CT) to map disease
    Purpose: define what to remove and when to re-operate.
    How it helps: MRI (with attention to “black turbinate” sign and orbital apex) and CT guide targeted, tissue-sparing surgery and monitor response. IMA India

13. Physical therapy and early mobilization
    Purpose: preserve strength and lung function.
    How it helps: lowers complications from prolonged bed rest and improves recovery after multiple operations.

14. Speech-language and swallow assessment; safe-feeding strategies
    Purpose: prevent aspiration and enable adequate intake after palatal/maxillary procedures.
    How it helps: tailored textures, obturators, and training protect nutrition.

15. Psychological support and counseling
    Purpose: address distress, anxiety, or body-image concerns (especially after facial surgery).
    How it helps: improves adherence, sleep, and resilience during a long recovery.

16. Environmental controls (HEPA filtration where available)
    Purpose: reduce spore exposure for high-risk inpatients.
    How it helps: lowers airborne fungal counts in rooms caring for immunocompromised patients.

17. Meticulous wound and sinus cavity care between operations
    Purpose: keep surgical fields clean and ready for healing.
    How it helps: lowers bioburden and prepares tissue for grafts or flaps.

18. Hyperbaric oxygen therapy (HBO) as an adjunct in selected cases
    Purpose: increase tissue oxygen and aid neutrophil killing in ischemic tissue.
    How it helps: small case series and reviews suggest possible benefit in diabetics with sinus disease, but evidence is limited and access varies; it should never delay surgery or antifungals. MDPIEurope PMC

19. Regular staged reassessment (about 4–6 weeks)
    Purpose: judge response and set the path from IV treatment to step-down therapy.
    How it helps: aligns with expert consensus for response checks using clinical status and imaging. PMC

20. Clear patient education on red flags
    Purpose: catch recurrence or progression early.
    How it helps: patients learn to report new facial pain, black nasal discharge or crusts, double vision, eyelid droop, worsening headache, or confusion immediately. Lippincott Journals

Drug treatments

Important: exact choices, doses, and duration must be individualized by your treating team based on kidney function, disease extent, drug interactions, and surgical findings.

1. Liposomal Amphotericin B (L-AmB) — first-line
   Class & purpose: polyene antifungal; rapidly reduces fungal burden.
   Dose & time: typically 5–10 mg/kg IV once daily; higher doses are often used for brain involvement; duration is weeks, then step-down to an oral azole when stable.
   Mechanism: binds ergosterol and forms pores in fungal membranes.
   Key side effects: kidney injury, low potassium and magnesium, infusion reactions—safer than deoxycholate but still monitored closely. ECMMHaematologicaPMC

2. Amphotericin B Lipid Complex (ABLC) — alternative if L-AmB unavailable/intolerant
   Dose & time: commonly 5 mg/kg IV daily for weeks, then step-down.
   Notes: similar efficacy with different toxicity profile; choice depends on availability and renal status. PMC

3. Amphotericin B Deoxycholate — resource-limited fallback
   Dose & time: ~1–1.5 mg/kg IV daily when liposomal formulations are not available.
   Notes: higher nephrotoxicity; not preferred when safer formulations can be used. InfezMed

4. Isavuconazole (isavuconazonium sulfate; brand CRESEMBA®) — step-down or alternative/primary when amphotericin is contraindicated
   Dose & time: 200 mg isavuconazole (372 mg isavuconazonium) every 8 hours for 6 doses, then 200 mg once daily (IV or oral; start maintenance 12–24 h after last loading dose).
   Purpose: maintenance or salvage therapy; good oral bioavailability.
   Mechanism: triazole that blocks ergosterol synthesis.
   Key side effects & cautions: liver enzyme elevation, GI upset, QT interval shortening (unique), and drug–drug interactions via CYP3A4. FDA Access DataDrugs.com

5. Posaconazole (delayed-release tablets or IV) — step-down, maintenance, or salvage
   Dose & time: 300 mg twice on day 1, then 300 mg once daily (tablet or IV); duration is typically many weeks until imaging and symptoms resolve.
   Mechanism: triazole that blocks fungal cell membrane synthesis.
   Key side effects & cautions: liver enzyme elevation, GI upset, drug interactions; Delayed-release tablets/IV achieve better exposure than old oral suspension. Therapeutic drug monitoring may be used in complex cases. Mayo ClinicECMM

6. Combination therapy (e.g., L-AmB + posaconazole or isavuconazole) — for severe or refractory disease
   Purpose: attempt broader coverage or synergy when progression continues.
   Notes: used by experts in difficult cases; the evidence base is limited, and combination therapy should be individualized. ASH Publications

7. Transcutaneous retrobulbar amphotericin B (TRAMB) — local orbital injections
   Purpose: deliver high local drug levels to the orbit to try to control early orbital disease and reduce the chance of exenteration.
   Typical protocols: 1 mL of 3.3–3.5 mg/mL amphotericin B (liposomal preferred in many series) given over several days or weekly courses, guided by imaging and response.
   Risks: orbital compartment syndrome, pain, hemorrhage; done only by experienced teams and always with systemic therapy and debridement. Evidence comes from case series and algorithms developed during COVID-19 outbreaks. PMCSpringerLinkAjo

8. Echinocandins (e.g., caspofungin) — selected salvage combination
   Purpose: sometimes added to L-AmB in refractory cases.
   Notes: Mucorales are generally resistant, but some clinicians use echinocandins for potential synergy; evidence is limited and this is not standard monotherapy. ASH Publications

9. Iron chelation with deferasirox — not routine; may be harmful
   Purpose/mechanism: theoretical—starve fungus of iron.
   Reality: one small randomized trial in humans showed worse outcomes with deferasirox added to L-AmB; therefore not recommended outside trials despite promising animal data. PMC+1

10. Supportive medicines around antifungals
    Purpose: protect kidneys (electrolyte replacement), manage nausea, and prevent line infections.
    Notes: these are individualized but critical to keeping patients on life-saving antifungals.

---

Dietary “molecular” supplements

These can support nutrition and healing during recovery with your clinician’s approval, especially because azole antifungals have many drug interactions. They do not treat mucormycosis and must not delay surgery or antifungals.

1. Vitamin D (e.g., 1000–2000 IU/day unless your doctor advises otherwise)
   Supports innate immunity and mucosal defenses; correct deficiency confirmed by a blood test.

2. Vitamin C (e.g., 500–1000 mg/day)
   Antioxidant support and collagen synthesis for wound healing; watch for kidney stone risk in predisposed people.

3. Zinc (up to 20–40 mg elemental/day, short term)
   Helps neutrophil and T-cell function; avoid long-term high doses (can lower copper levels).

4. Selenium (50–100 mcg/day)
   Selenoproteins help limit oxidative stress and support immune signaling.

5. Omega-3 fatty acids (EPA/DHA ~1 g/day)
   May help inflammation resolution and calorie intake for undernourished patients.

6. High-quality protein (e.g., whey 20–40 g/day if intake is low)
   Supplies amino acids (including leucine) to maintain lean mass and repair tissue.

7. B-complex vitamins (at RDA levels)
   Support energy metabolism and nerve health, especially after prolonged illness.

8. N-Acetylcysteine (600–1200 mg/day if approved)
   Antioxidant and glutathione precursor; avoid if it interferes with other treatments.

9. Curcumin (standardized extract if approved)
   Antioxidant/anti-inflammatory support; potential interactions with anticoagulants/antiplatelets must be considered.

10. Probiotic food choices (e.g., pasteurized yogurt) if safe
    May support gut health during long antibiotic courses; avoid probiotic pills or live cultures if severely immunocompromised unless your team approves.

Avoid grapefruit, Seville orange, and St. John’s wort because they alter azole levels and can cause serious interactions.

---

Regenerative adjuncts

There are no proven “stem-cell drugs” for ROCM. The options below are adjunctive and considered in select, severe, or refractory cases—always with antifungals and surgery, and only by experienced teams.

1. G-CSF (filgrastim)
   Dose example: ~5 mcg/kg/day subcutaneously until neutrophils recover (doctor-adjusted).
   Function/mechanism: raises neutrophil counts and activity.
   Evidence: case reports/series suggest benefit mainly when neutropenia is present. Haematologica

2. GM-CSF (sargramostim)
   Dose example: commonly 125–250 mcg/m²/day (or intermittent dosing) under close monitoring.
   Function: stimulates neutrophil and macrophage function; may enhance killing of fungi.
   Evidence: adjunctive use reported for difficult invasive fungal infections, including mucor, but controlled data are lacking. PMCScienceDirect

3. Interferon-gamma (IFN-γ1b)
   Dose example: regimens like 50 mcg/m² subcutaneously three times weekly have been reported.
   Function: activates macrophages and Th1 immunity.
   Evidence: case reports show potential benefit in refractory mucormycosis; still experimental. PMC

4. Granulocyte transfusions
   Dose example: high-dose transfusions (often ≥1×10¹⁰ granulocytes per infusion) from stimulated donors.
   Function: provides immediate neutrophil function while the patient’s marrow recovers.
   Evidence: used in profound neutropenia with mixed results; reserved for select ICU cases. PMC

5. Immune-checkpoint inhibitor “rescue” (e.g., nivolumab) with IFN-γ in exceptional cases
   Function: attempts to reverse immune exhaustion in relentless infection.
   Evidence: very limited case-level data; not standard of care. The LancetFrontiers

6. Interleukin-7 (IL-7) in profound lymphopenia—rare, research-level
   Function: promotes T-cell recovery.
   Evidence: isolated reports in invasive fungal disease; not established for mucormycosis. Lippincott Journals

These therapies are not substitutes for amphotericin-based therapy and timely surgery.

---

Surgeries

1. Endoscopic sinus debridement
   What happens: ENT surgeons enter the nasal cavity with an endoscope to remove dead tissue and fungal debris from the turbinates, septum, and sinuses.
   Why it’s done: dead tissue has no blood supply, so drugs cannot reach it. Removing it reduces fungal burden and restores drainage and oxygen to the area, slowing spread to orbit and brain. PMC

2. Medial maxillectomy or partial/total maxillectomy
   What happens: surgeons remove parts of the maxillary sinus walls and any necrotic upper jaw bone.
   Why it’s done: the maxilla is commonly involved in ROCM; removing nonviable bone prevents further invasion and prepares the site for later reconstruction.

3. Orbital decompression and debridement; orbital exenteration when necessary
   What happens: in early or limited orbital disease, decompression and local debridement plus TRAMB may preserve the eye. If the orbit is non-viable or life-threatening spread is occurring, removal of the eye and soft tissues (exenteration) may be required.
   Why it’s done: to save life and, when possible, preserve vision or at least the eyelids for function and reconstruction. Ajo

4. Skull base/cranial debridement
   What happens: neurosurgeons remove infected bone and necrotic tissue at the skull base or brain surface, sometimes with drainage of abscesses.
   Why it’s done: when imaging shows intracranial extension, aggressive source control prevents catastrophic complications.

5. Palatal resection with obturator or flap reconstruction
   What happens: removal of necrotic palate followed by temporary obturator; later, regional or free-flap reconstruction.
   Why it’s done: prevents ongoing sinus-oral contamination, restores speech and swallowing, and supports nutrition during recovery.

---

Practical prevention

1. Keep diabetes well controlled; seek urgent care for any signs of ketoacidosis (nausea, abdominal pain, rapid breathing). CDC

2. Use steroids only when clearly indicated, at the lowest effective dose and shortest time. PMC

3. Ensure oxygen therapy and humidifiers use sterile water and clean equipment in hospitals and at home. World Health Organization

4. Avoid dusty construction sites and poorly ventilated, moldy spaces during recovery; use a good mask if exposure is unavoidable. CDC

5. Maintain good oral and sinus hygiene; treat dental problems early.

6. Protect skin with gloves and footwear when gardening; wash and cover wounds promptly. CDC

7. Be alert to red flags—facial pain or numbness, black nasal crusts/discharge, sudden eye pain, swelling, double vision, or new headache. Seek urgent care. Lippincott Journals

8. Manage iron carefully; avoid unnecessary iron infusions or deferoxamine in high-risk settings, and follow medical advice for iron overload. Oxford Academic

9. Plan early follow-ups after severe COVID-19 or ICU stays if you have diabetes or immunosuppression. World Health Organization

10. Choose care centers with experience in mucormycosis management when possible; outcomes improve with coordinated, multimodal care. PMC

---

When to see a doctor—immediately

Seek emergency care the moment you notice any of the following, especially if you have diabetes, recent steroid use, cancer treatment, transplant, or severe COVID-19:

• One-sided nasal blockage, facial or tooth pain, blackish nasal crusts or discharge, facial swelling or numbness, or palate discoloration.

• Eye pain, new redness or swelling around the eye, double vision, eyelid droop, sudden decrease in vision.

• Persistent or worsening headache, confusion, weakness, seizures, or fever that does not settle.
  These are classic red flags for ROCM and need same-day evaluation and imaging. Lippincott Journals

---

What to eat and what to avoid

What to eat

1. Steady, diabetes-friendly meals: plate method with non-starchy vegetables, lean protein, and whole-grain portions matched to your glucose plan.

2. High-protein foods at every meal: eggs, fish, poultry, tofu, legumes, or dairy to support healing.

3. Healthy fats: olive oil, nuts, seeds, and omega-3-rich fish to support energy and inflammation balance.

4. Soft, moist textures if you have palatal or maxillary surgeries; use an obturator if prescribed.

5. Plenty of safe fluids: water and oral rehydration to maintain kidney perfusion during amphotericin therapy.

What to avoid

1. Sugary drinks and ultra-refined sweets that spike glucose.

2. Alcohol, which worsens dehydration and drug interactions.

3. Grapefruit/Seville orange (and St. John’s wort) because they interact with azole antifungals.

4. Unpasteurized or visibly moldy foods and raw sprouts while immunocompromised.

5. Very high-salt diets that aggravate amphotericin-related electrolyte issues.

---

FAQs

1) Is ROCM contagious?
No. You cannot catch it from another person. The fungus is in the environment; risk rises when immunity is weak. CDC

2) What starts treatment?
Doctors start IV liposomal amphotericin B quickly and plan urgent debridement of dead tissue. Delay worsens outcomes. ECMMPMC

3) How long will I need antifungals?
Often many weeks of IV therapy followed by weeks to months of oral isavuconazole or posaconazole until scans and symptoms settle. Your team monitors labs and imaging to decide. FDA Access DataMayo ClinicPMC

4) Will I need surgery?
Most patients do. Removing dead tissue allows drugs to reach living areas and slows spread. Multiple procedures may be needed. PMC

5) Can my vision be saved?
Sometimes yes—if disease is caught early and treated aggressively (systemic drugs, endoscopic debridement, and selected TRAMB). If the orbit is non-viable, exenteration may be lifesaving. Ajo

6) Why can’t I just take oral antifungals from the start?
Because severe ROCM needs rapid, high tissue levels that IV amphotericin provides. Oral step-down comes later once you are stable. ECMM

7) Is hyperbaric oxygen a cure?
No. It is an adjunct that may help in select cases but must not delay surgery or antifungals. Evidence is limited. MDPI

8) Do iron chelators help?
The chelator deferasirox looked promising in animals but performed worse than standard care in a small human trial. It is not recommended outside research. PMC

9) Can supplements cure mucormycosis?
No. Supplements only support nutrition. Antifungal drugs and surgery are the treatments that save lives. CDC

10) How will doctors reduce kidney risks from amphotericin?
They check creatinine and electrolytes often, give fluids and magnesium/potassium, and switch to azoles if toxicity occurs. PMC

11) What follow-up tests will I need?
Repeat clinical exams and imaging (CT/MRI) at intervals—commonly around 4–6 weeks—to see if the infection is shrinking and if surgery or drug changes are needed. PMC

12) What makes ROCM more likely after COVID-19?
Diabetes, heavy or prolonged steroid use, severe illness, and sometimes poor oxygen-equipment hygiene were key factors seen during outbreaks. World Health Organization

13) Is posaconazole the same as isavuconazole?
No. Both are triazoles used for step-down or salvage, but dosing, interactions, and side-effect profiles differ. Your team chooses based on your case. Mayo ClinicFDA Access Data

14) Can ROCM come back?
Yes. Recurrence risk is higher if underlying problems (like diabetes) are not controlled or if treatment stops too early. Close follow-up is essential. CDC

15) What can I do right now to help myself?
Keep glucose in target range, take medicines exactly as prescribed, keep equipment clean and sterile, attend all follow-ups, and report new symptoms immediately. World Health Organization

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 24, 2025.